Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Zonegran
Generic Name: Zonisamide
Zonisamide is an anticonvulsant drug that is used in combination with other medications to treat partial seizures in children over 16 years of age and adults with epilepsy. Off label it is used for Bipolar disorder.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Epilepsy | 190 | 63 |
|
|
|
|
|
| Seizures (complex partial) | 18 | 9 |
|
|
|
|
|
| Migraine headaches | 13 | 2 |
|
|
|||
| Seizures | 8 | 0 | |||||
| Nerve pain (neuralgia) | 7 | 1 |
|
||||
| Other | 7 | 1 |
|
See all 257 patients currently taking Zonisamide
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Zonisamide
| Memory problems | 5 | |
|---|---|---|
| Fatigue | 3 | |
| Weight loss | 3 | |
| Irritability | 3 | |
| Chest tightness | 3 | |
| Headaches | 2 | |
| See all 55 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Zonisamide. See all 17 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 30 | ||
| Did not seem to work | 23 | ||
| Doctor's advice | 18 | ||
| Other | 5 | ||
| Expense | 4 | ||
| Course of treatment ended | 4 | ||
| Personal research | 3 | ||
| Change in health plan coverage | 3 | ||
| Not indicated | 2 |
Adherence
Taking treatment as prescribed
Adherence of Zonisamide
Always |
72 | 84% |
|
|---|---|---|---|
Usually |
11 | 13% |
|
Sometimes |
1 | 1% |
|
Never |
2 | 2% |
|
Burden
Difficulty being on treatment
Burden of Zonisamide
Very |
5 | 6% |
|
|---|---|---|---|
Somewhat |
2 | 2% |
|
A little |
14 | 16% |
|
Not at all |
65 | 76% |
|
Cost
Paid out of pocket
Cost of Zonisamide
$200+ |
3 | 6% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
3 | 6% |
|
$25-49 |
10 | 20% |
|
< $25 |
35 | 69% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 12, 2012.